Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
The first quarter of the year brought with it some major selling in the momentum names, specifically in biotech stocks.
Since then, the overall stock market has recovered, and so have most biotech stocks with it. Unfortunately, while the market has hit new highs, most biotechs have not.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Some biotech stocks, however, have performed better than others, and some have actually outperformed the overall market in recent weeks.
It starts with Illumina (NASDAQ: ILMN). Illumina develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation and function in the biotech industry.
Illumina’s stock stalled repeatedly at $180 back in February and March. The stock has now approached that old high and seems poised to break out.
Another biotech stock that has performed well, and actually better than the overall market, is Pacira Pharmaceuticals (NASDAQ: PCRX).The company develops, commercializes and manufactures pharmaceutical products primarily for use in hospitals and ambulatory surgery centers worldwide.
Want Private Access to Benzinga Analyst?
Check out the latest strategies our team of experts are using every week so that you can always adapt to the market like the pros!—Get FULL Access to This Week's Webinar Here.
Not only has Pacira reached its $83, February peak, the stock has actually exceeded it and continues to hit new 52-week highs.
Lastly, InterMune Pharmaceuticals’ (NASDAQ: ITMN) stock performance has been nothing short of impressive.
InterMune popped to $38 back in February and March before eventually falling to $24.
The stock has now went on to hit high after high.
If investors and traders think the market’s new highs have legs and want to try to ride the biotech train again, take a good look at these leaders for opportunities!
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.